Nov 10, 2016 12:01 pm UTC| Business
SAN DIEGO and TORONTO, Nov. 10, 2016 -- Aptose Biosciences Inc. (Aptose) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of...
Boxwood Launches Environmental Giving Campaign
Nov 10, 2016 12:00 pm UTC| Business
Stamford, Conn., Nov. 10, 2016 -- Boxwood Means, LLC, a leading provider of property valuations and data analytics in the U.S. small-cap commercial real estate market, is pleased to announce that it is pledging a...
Kamada Reports Financial Results for the Third Quarter and Nine Months of 2016
Nov 10, 2016 12:00 pm UTC| Business
Total Revenues for Third Quarter 2016 Grew 21% to $19.4 Million vs. Third Quarter 2015 Proprietary Products Revenue Grew 57% to $15.0 Million in Third Quarter 2016 vs. Third Quarter 2015 Company Reiterates 2016...
Neos Therapeutics Reports Third Quarter 2016 Financial Results
Nov 10, 2016 12:00 pm UTC| Business
DALLAS/FORT WORTH, Texas, Nov. 10, 2016 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products for the...
Mitek to Participate at the ROTH Technology Corporate Access Day in New York on November 16, 2016
Nov 10, 2016 12:00 pm UTC| Business
SAN DIEGO, Nov. 10, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced it will participate at the 2nd Annual ROTH...
Bio-Path Holdings Reports Third Quarter 2016 Financial Results
Nov 10, 2016 12:00 pm UTC| Business
HOUSTON, Nov. 10, 2016 -- Bio-Path Holdings, Inc. (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Opiant Pharmaceuticals, Inc. Announces Appointment of Thomas T. Thomas to Board of Directors
Nov 10, 2016 12:00 pm UTC| Business
SANTA MONICA, Calif., Nov. 10, 2016 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...